Back
Pliant Therapeutics Stock Price Chart
The EXACT DAY Certain Stocks Soar - Year After Year
Find out now - completely free of charge.
Buy
52
PLRX
Pliant Therapeutics
Last Price:
$1.62
Seasonality Move:
44.98%
7 Day Trial
ALL ACCESS PASS
$
7
Here's the Best Day to Buy Nvidia
Click here to see the green days for 5 major stocks today.-
The current trend is relatively stagnant and PLRX is experiencing slight selling pressure.
Pliant Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.5 | Buy |
| 20-day SMA: | 1.42 | Buy |
| 50-day SMA: | 1.43 | Buy |
| 200-day SMA: | 8.44 | Sell |
| 8-day EMA: | 1.53 | Buy |
| 20-day EMA: | 1.47 | Buy |
| 50-day EMA: | 1.93 | Sell |
| 200-day EMA: | 6.87 | Sell |
Pliant Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 60.27 | Buy |
| Chaikin Money Flow: | -358043 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.32 - 1.56) | Buy |
| Bollinger Bands (100): | (-0.23 - 7.45) | Sell |
Pliant Therapeutics Technical Analysis
| May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Pliant Therapeutics Stock
Is Pliant Therapeutics Stock a Buy?
-
Pliant Therapeutics share price is 1.63 while PLRX 8-day simple moving average is 1.50, which is a Buy signal.
-
The stock price of PLRX is 1.63 while Pliant Therapeutics 20-day SMA is 1.42, which makes it a Buy.
-
Pliant Therapeutics 50-day simple moving average is 1.43 while PLRX share price is 1.63, making it a Buy technically.
-
PLRX stock price is 1.63 and Pliant Therapeutics 200-day simple moving average is 8.44, creating a Sell signal.
PLRX Technical Analysis vs Fundamental Analysis
Buy
52
Pliant Therapeutics (PLRX)
is a Buy
Is Pliant Therapeutics a Buy or a Sell?
-
Pliant Therapeutics stock is rated a BuyThe current Pliant Therapeutics [PLRX] share price is $1.63. The Score for PLRX is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
Pliant Therapeutics Stock Info
Market Cap:
100.1M
Price in USD:
1.63
Share Volume:
956.8K
Pliant Therapeutics 52-Week Range
52-Week High:
16.10
52-Week Low:
1.10
Buy
52
Pliant Therapeutics (PLRX)
is a Buy
Pliant Therapeutics Share Price Forecast
-
What is the Pliant Therapeutics stock price today?The Pliant Therapeutics stock price is 1.63 USD today.
-
Will PLRX stock go up or go down?Pliant Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Pliant Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Pliant Therapeutics is not overvalued.
Is Pliant Therapeutics Stock a Buy?
-
Pliant Therapeutics share price is 1.63 while PLRX 8-day exponential moving average is 1.53, which is a Buy signal.
-
The stock price of PLRX is 1.63 while Pliant Therapeutics 20-day EMA is 1.47, which makes it a Buy.
-
Pliant Therapeutics 50-day exponential moving average is 1.93 while PLRX share price is 1.63, making it a Sell technically.
-
PLRX stock price is 1.63 and Pliant Therapeutics 200-day simple moving average is 6.87, creating a Sell signal.
Fundamental Analysis of Pliant Therapeutics
Is Pliant Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.50 per share, a decrease next quarter of $0.13 per share, an increase this year of $1.09 per share, and an increase next year of $0.08 per share.
Technical Analysis of Pliant Therapeutics
Should I short Pliant Therapeutics stock?
-
PLRX Moving Average Covergence Divergence (MACD) indicator is 0.01, suggesting Pliant Therapeutics is a Buy
-
Pliant Therapeutics Relative Strength Index (RSI) is 60.27, which suggest Pliant Therapeutics is overbought
-
The Bollinger Bands (25) for Pliant Therapeutics is (1.32 - 1.56), which suggest Pliant Therapeutics is a Sell
-
The Bollinger Bands (100) for Pliant Therapeutics is (-0.23 - 7.45), which suggest Pliant Therapeutics is a Sell
* Pliant Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.